These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 3328906)

  • 61. [New basic preparations with prolonged action in the treatment of rheumatoid arthritis].
    Tumanova IG; Sigidin IaA
    Ter Arkh; 1987; 59(4):80-3. PubMed ID: 2884735
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Continuous chrysotherapy of rheumatoid disease (evaluation of a retrospective study of 42 cases)].
    D'eshougues JR; Delcambre B; Maquerlot M; Defrance D
    Lille Med; 1977; 22(7):430-8. PubMed ID: 412025
    [No Abstract]   [Full Text] [Related]  

  • 63. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
    Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
    Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intramuscular gold for rheumatoid arthritis.
    Philips VK
    Compr Ther; 1977 Jun; 3(6):26-31. PubMed ID: 141355
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Nephrotic syndrome--rare complication of gold therapy].
    Klepikov PV; Nikolaev AIu; Varshavskiĭ VA; Pal'tsev MA; Androsova SO
    Ter Arkh; 1983; 55(10):98-101. PubMed ID: 6359555
    [No Abstract]   [Full Text] [Related]  

  • 66. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial.
    Giannini EH; Barron KS; Spencer CH; Person DA; Baum J; Bernstein BH; Kredich DW; Jacobs JC; Zemel LS; Gibbas D
    J Rheumatol; 1991 Aug; 18(8):1240-2. PubMed ID: 1941832
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
    Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L
    J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of auranofin and other gold complexes on the activity of phospholipase C.
    Snyder RM; Mirabelli CK; Clark MA; Ziegler JT; Crooke ST
    Mol Pharmacol; 1987 Sep; 32(3):437-42. PubMed ID: 3118179
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
    Rainer F; Ulreich A
    Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
    [No Abstract]   [Full Text] [Related]  

  • 71. [Gold salts in the therapy of rheumatoid arthritis. Experience with an oral preparation].
    Magarò M; Zoli A; Altomonte L; Mirone L; Corvino G; Carelli G
    Recenti Prog Med; 1986 Jun; 77(6):319-20. PubMed ID: 3764073
    [No Abstract]   [Full Text] [Related]  

  • 72. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intrarticular methotrexate in the therapy of rheumatoid arthritis.
    Franchi F; Seminara P; Codacci-Pisanelli G; Aronne T; Avella A; Bonomo L
    Recenti Prog Med; 1989 May; 80(5):261-2. PubMed ID: 2762663
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The cost effectiveness of auranofin: results of a randomized clinical trial.
    Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED
    J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rheumatoid arthritis therapy: the slow-acting agents.
    Hardin JG
    Hosp Pract (Off Ed); 1989 Jun; 24(6):163-8, 170, 173-8. PubMed ID: 2566617
    [No Abstract]   [Full Text] [Related]  

  • 77. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cigarette smoking and the clinical outcome of gold therapy in rheumatoid arthritis.
    Lewis D; Capell HA; McNeil CJ; Smith WE; Brown DH
    J Rheumatol; 1984 Feb; 11(1):111-2. PubMed ID: 6422040
    [No Abstract]   [Full Text] [Related]  

  • 79. [Phagocytic activity in rheumatoid arthritis].
    Jelcić A; Car A; Gnjidić Z; Sabioncello A
    Reumatizam; 1992; 39(2):17-9. PubMed ID: 1366147
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Gold-induced dermatitis (contact dermatitis and toxiderma)].
    Kalamkarian AA; Somov BA; Fedorov SM; Persina IS
    Vestn Dermatol Venerol; 1985 Aug; (8):4-8. PubMed ID: 2933891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.